Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis

• Published in: Cancer medicine (Malden, MA) MA), 2021-03, Vol.10 (6), p.2100-2111
• Main Authors: Yang, Yun, Lin, Kongying, Liu, Lei, Qian, Youwen, Yang, Yuan, Yuan, Shengxian, Zhu, Peng, Huang, Jian, Liu, Fuchen, Gu, Fangming, Fu, Siyuan, Jiang, Beige, Liu, Hui, Pan, Zeya, Lau, Wan Yee, Zhou, Weiping
• Format: Article
• Language: English
• Subjects: Abdomen; Ablation; Antigens; Blood tests; Catheters; Chemotherapy; Clinical Cancer Research; Deoxyribonucleic acid; DNA; Hepatectomy; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Liver cancer; Magnetic resonance imaging; Medical imaging; Medical prognosis; Metastasis; microvascular invasion; Microvasculature; Original Research; Patients; Prognosis; Serology; Statistical analysis; Surgery; Survival; transcatheter arterial chemoembolization; Tumors; Veins & arteries
• ISSN: 2045-7634; 2045-7634
• DOI: 10.1002/cam4.3814

Background To study the influence of preoperative transcatheter arterial chemoembolization (TACE) on the incidence of microvascular invasion (MVI) and long‐term survival outcomes in hepatocellular carcinoma (HCC) patients. Methods Between January 1, 2010 and December 1, 2014, consecutive HCC patients who underwent curative liver resection were enrolled in this study. Univariable and multivariable regression analyses were used to identify independent predictive factors of MVI. Propensity score matching (PSM) was used to compare the incidences of MVI and prognosis between patients who did and did not receive preoperative TACE. Factors associated with Disease‐Free Survival (DFS) and Overall survival (OS) were identified using Cox regression analyses. Results Of 1624 patients, 590 received preoperative TACE. The incidence of MVI was significantly lower in patients with preoperative TACE than those without preoperative TACE (39.15% vs. 45.36%, p = 0.015). After PSM, the incidences of MVI were similar in the two groups (38.85% vs. 41.10%, p = 0.473). Multivariable regression analysis revealed preoperative TACE to have no impact on the incidence of MVI. Before PSM, survival of patients with preoperative TACE was significantly worse than those without preoperative TACE (p = 0.032 for DFS and p = 0.027 for OS). After PSM, the difference became insignificant (p = 0.465 for DFS and p = 0.307 for OS). After adjustment for other prognostic variables in the propensity‐matched cohort, preoperative TACE was still found not to be associated with DFS and OS after HCC resection. Both before and after PSM, the prognosis of patients was not significantly different between the two groups for BCLC stages 0, A, and B. Conclusions Preoperative TACE did not influence the incidence of MVI and prognosis of patients with HCC who underwent ‘curative’ liver resection. Preoperative TACE did not influence the incidence of MVI and prognosis of patients with HCC who underwent ‘curative’ liver resection.